Flavoxate hydrochloride supplier

Name
Flavoxate hydrochloride
EINECS 223-066-4
CAS No. 3717-88-2
Density 1.203 g/cm³
Solubility Soluble in water
Melting Point 232-234 °C
Formula C₂₄H₂₆ClNO₄
Boiling Point 564.1 °C at 760 mmHg
Molecular Weight 427.928
Flash Point 294.9 °C
Transport Information
Appearance crystalline solid
Safety 26
Risk Codes 22-36/37/38
Molecular Structure
Hazard Symbols Xn
Synonyms 4H-1-Benzopyran-8-carboxylicacid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester, hydrochloride(9CI);1-Piperidineethanol,3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate (ester), hydrochloride(8CI);Bladderon;Genurin;Patricin;Peflate;Piperidinoethyl-3-methylflavone-8-carboxylate hydrochloride;Spasmal;Spasuret;Urispas;
PSA 59.75000
LogP 5.15100

Flavoxate hydrochloride Specification

The Flavoxate hydrochloride, with the CAS registry number 3717-88-2,is also known as 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester hydrochloride. It belongs to the product categories of 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester hydrochloride. This chemical's molecular formula is C₂₄H₂₅NO₄^.HCl;C₂₄H₂₆ClNO₄and molecular weight is 427.93.Its EINECS number is 223-066-4. What's more,Its systematic name is Flavoxate hydrochloride. It is a Crystalline Solid which is a drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist. It is harmful if swallowed and irritating to eyes, respiratory system and skin .In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

Physical properties about Flavoxate hydrochloride are:
(1)ACD/LogP: 5.184; (2)# of Rule of 5 Violations: 1; (3)#H bond acceptors: 5; (4)#H bond donors: 0; (5)#Freely Rotating Bonds: 6; (6)Flash Point: 294.9 °C; (7)Enthalpy of Vaporization: 84.76 kJ/mol ; (8)Boiling Point: 564.1 °C at 760 mmHg; (9)Vapour Pressure: 9.56E-13 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES:Cl.O=C(OCCN1CCCCC1)c4cccc2c4O/C(=C(\C2=O)C)c3ccccc3;
(2)Std. InChI:InChI=1S/C24H25NO4.ClH/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25;/h2,4-5,8-12H,3,6-7,13-16H2,1H3;1H;
(3)Std. InChIKey:XOEVKNFZUQEERE-UHFFFAOYSA-N.

The toxicity data of Flavoxate hydrochloride are as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	350mg/kg (350mg/kg)	BEHAVIORAL: ANALGESIA AUTONOMIC NERVOUS SYSTEM: "SMOOTH MUSCLE RELAXANT (MECHANISM UNDEFINED, SPASMOLYTIC)" PERIPHERAL NERVE AND SENSATION: LOCAL ANESTHETIC	Archives Internationales de Pharmacodynamie et de Therapie. Vol. 131, Pg. 187, 1961.
mouse	LD50	intravenous	28mg/kg (28mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 232, 1979.
mouse	LD50	oral	740mg/kg (740mg/kg)	BEHAVIORAL: EXCITEMENT BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)	Journal of Pharmacology and Experimental Therapeutics. Vol. 130, Pg. 356, 1960.
mouse	LD50	subcutaneous	610mg/kg (610mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 232, 1979.
rabbit	LD50	intravenous	25mg/kg (25mg/kg)		Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 3, Pg. 1214, 1975.
rabbit	LD50	oral	> 6gm/kg (6000mg/kg)		Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 3, Pg. 1214, 1975.
rat	LD50	intraperitoneal	170mg/kg (170mg/kg)	GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 5271, 1987.
rat	LD50	intravenous	25mg/kg (25mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 232, 1979.
rat	LD50	oral	1040mg/kg (1040mg/kg)	LUNGS, THORAX, OR RESPIRATION: CYANOSIS GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 5271, 1987.
rat	LD50	subcutaneous	1010mg/kg (1010mg/kg)		Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 232, 1979.

Product Name

Flavoxate hydrochloride

Flavoxate hydrochloride Specification

Related Products

Hot Products